We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare Products Regulatory Agency (MHRA) took part in the annual global coordinated operation to tackle the illegal online sale of medicines and medical devices.
Thousands of adults and children will benefit from new services launched across England to help them achieve a healthy weight and boost their wellbeing.
First published during the 2019 to 2022 Johnson Conservative government
The CMA is consulting on proposed commitments from Essential Pharma to keep a key bipolar drug on the market, and ensure it is affordable to the NHS.
Upper Tribunal Administrative Appeals Chamber decision by Judge Grey KC on 2 March 2023.
An increasing number of bogus medical products being sold through unauthorised websites claiming to treat or prevent COVID-19 are being investigated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Public Health England has today published new data detailing the state of the nation’s diet.
MHRA are revealing a different fact about the issue of fake and unlicensed medical products every day in December leading up to Christmas.
If pioglitazone is used in combination with insulin patients should be observed for signs and symptoms of heart failure, weight gain, and oedema.
Test for raised ketones in patients with ketoacidosis symptoms, even if plasma glucose levels are near-normal.
G.L Pharma GmbH T/A Healthcare Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the specified batches is missing important safety relevant text changes.
Gedeon Richter (UK) Ltd is recalling all unexpired stock of Esmya 5 mg tablets from patients, pharmacies and wholesalers following a new case of liver failure requiring liver transplant in a patient taking the medicine.
Pfizer is recalling the above batches as a precaution due to an out of specification result for microbiological testing during routine stability studies on a batch of the product which was not released to the market. (EL (17) A/12)
Ten top tips for buying medicines and medical devices online safely
(Generics (UK) Limited, trading as Mylan UK) A small number of packs from a specific batch may have an over count or under count of one tablet (EL (15)A/05).
Innovate UK-supported life science company Phynova finds further evidence that its plant-based food ingredient promotes healthy blood sugar.
(Laboratoire SERB) EAN barcode is incorrect – when scanned, it identifies the product as Primidone SERB 250mg tablets not 50mg tablets (EL (15)A/10)
Accord Healthcare Limited is recalling a specific batch which has inadvertently been distributed in the UK, because it is labelled for the Portuguese market.
Public Health Minister, Jane Ellison, launches the Responsibility Deal Saturated Fat Reduction Pledge.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Torrent Pharma (UK) Ltd is recalling the below batches as a precaution because out of specification results for dissolution were obtained during routine stability testing.
There have been reports of necrotising and haemorrhagic pancreatitis in people taking exenatide some of which were fatal - stop exenatide treatment if pancreatitis is diagnosed.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).